Yimaikang Tablet

Yimaikang Tablet is a traditional Chinese herbal medicine extracted and isolated from Erigerontis Herba. It is indicated for the treatment of various cardiovascular and cerebrovascular diseases, including ischemic cerebrovascular disease, paralysis after cerebral hemorrhage, fundus retinal vein occlusion, coronary heart disease, vasculitic dermatosis, and rheumatism. The drug functions by promoting blood circulation, removing blood stasis, and improving microcirculation. It enhances cerebrovascular and cardiac blood flow, improves myocardial ischemia and hypoxia tolerance, dilates peripheral blood vessels, and increases skin capillary permeability and local tissue blood flow. Preclinical studies have also shown its ability to reduce malondialdehyde content, increase superoxide dismutase activity, and decrease retinal blood vessel permeability. It is manufactured by Kunming Sinoway Pharmaceutical Co. Ltd. and has received SFDA approval in China.

Other names

Yimaikang PianYimaikang tablets